Production process analysis: a review of the device history record confirmed that the device was manufactured and tested according to relevant procedures, and shipped according to manufacturer's specifications.User (surgeon and patient) information analysis: patient #737 index procedure was performed on (b)(6) 2022.On 05-jun-2023 apifix was notified that patient #737 underwent removal surgery (that day) due to apifix distal bolt lateral migration and dislodgement from bone. patient to transition to magec rods as temporizing device until definitive fusion.On 07-jun_2023 apifix reached out to the surgeon for additional information, however no additional information has been received.On 19-jun-2023 additional information was received.The patient had no symptoms.Routine after-care and x-rays showed that the device was "failing".X-ray images provided suggest screw migration, and it was thought that the distal screw had migrated, however, in the removal (according to the surgeon) the screw was in bone. although the x-rays suggested screw migration, the surgeon noted there was no migration.Apifix can neither confirm nor rule out that screw pull-out occurred.Apifix was notified that the implants will not be returned to manufacturer.Risk assessment: reoperation events are a known risk that was assessed and recorded by the product risk management file.The risk of screw pullout has been assessed and found to be acceptable the current screw pullout rate due to any reason is in line with the rate reported in the literature for this type of complication as described in the company's cer (clinical evaluation report).The risk has been quantified, characterized, and documented as acceptable within a full risk assessment.Apifix is closing this complaint, but will continue to monitor this 'failure mode'; complaint trending will continue to monitor per post marketing surveillance procedure.If any further relevant information is identified, the complaint file will be reopened and a supplemental medwatch will be filed.
|